News InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 Continue Reading Previous InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904Next Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors Related Stories News TMX Group Thanksgiving Holiday Market Closures News TIPAK Marks Path to Leadership in Packaging Solutions Following Listing on SET News Chervon Names Daniel L. Abbott Director of Sales – Western U.S.A. News Chervon Names Peter J. Carlson Director of Sales for Strategic Accounts News Chervon Appoints Neil Harrison to the Position of VP Sales, Marketing and MD for Chervon Canada News Pelican Announces Appointment of Nino Di Teodoro to Its Board of Directors